UA26326C2 - METHOD OF TREATMENT OF DISEASES OF VIRAL AND BACTERIAL ETIOLOGY IN HUMANS AND ANIMALS AND COMPOSITION FOR ITS IMPLEMENTATION - Google Patents

METHOD OF TREATMENT OF DISEASES OF VIRAL AND BACTERIAL ETIOLOGY IN HUMANS AND ANIMALS AND COMPOSITION FOR ITS IMPLEMENTATION

Info

Publication number
UA26326C2
UA26326C2 UA4743095A UA4743095A UA26326C2 UA 26326 C2 UA26326 C2 UA 26326C2 UA 4743095 A UA4743095 A UA 4743095A UA 4743095 A UA4743095 A UA 4743095A UA 26326 C2 UA26326 C2 UA 26326C2
Authority
UA
Ukraine
Prior art keywords
humans
animals
viral
diseases
implementation
Prior art date
Application number
UA4743095A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вітольд Кічка
Витольд Кичка
Original Assignee
Hіка Хелт Продактс Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hіка Хелт Продактс Лімітед filed Critical Hіка Хелт Продактс Лімітед
Priority claimed from PCT/US1988/001785 external-priority patent/WO1989011294A1/en
Publication of UA26326C2 publication Critical patent/UA26326C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for treating viral and bacterial diseases in humans and animals provides for the administration of the therapeutically effective amount of the composition containing the active ingredient and the pharmaceutically acceptable carriers. Lysozyme dimer or ribonuclease A dimer is used as an active ingredient.
UA4743095A 1988-05-26 1988-05-26 METHOD OF TREATMENT OF DISEASES OF VIRAL AND BACTERIAL ETIOLOGY IN HUMANS AND ANIMALS AND COMPOSITION FOR ITS IMPLEMENTATION UA26326C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
UA26326C2 true UA26326C2 (en) 1999-08-30

Family

ID=35006604

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4743095A UA26326C2 (en) 1988-05-26 1988-05-26 METHOD OF TREATMENT OF DISEASES OF VIRAL AND BACTERIAL ETIOLOGY IN HUMANS AND ANIMALS AND COMPOSITION FOR ITS IMPLEMENTATION

Country Status (4)

Country Link
KR (1) KR930004599B1 (en)
AR (1) AR240542A1 (en)
MY (1) MY106984A (en)
UA (1) UA26326C2 (en)

Also Published As

Publication number Publication date
KR900701307A (en) 1990-12-01
AR240542A1 (en) 1990-05-31
MY106984A (en) 1995-08-30
KR930004599B1 (en) 1993-06-01

Similar Documents

Publication Publication Date Title
LV10054A (en) Anti-viral antibacterial compound and method of administration
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
IT1190403B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE TO TREAT THE HUMAN BODY WITH IT
FI842406A (en) LAONGVERKANDE KEFAKLORFORMULATION.
FI103180B1 (en) Preparation of drugs containing flurbiprofen for the control of pain and / or inflammation in animals and humans
DE3382458D1 (en) HAIR GROWTH AGENT.
RU94020410A (en) Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
EE9900428A (en) Anti-cough formulations
DE60237721D1 (en) COMBINATION THERAPY WITH OMEGA INTERFERON FOR THE TREATMENT OF HEPATITIS C VIRUS OR YELLOW VIRUS INFECTIONS
DK607885A (en) MEDICINAL PREPARATIONS WITH REDUCED TOXICITY
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
AU5643299A (en) Humic acid and its use in the treatment of various conditions
DE60028559D1 (en) TREATMENT OF MULTIPLERSCLEROSIS WITH A COMBINATION OF INTERFERON AND GROWTH HORMONE
UA26326C2 (en) METHOD OF TREATMENT OF DISEASES OF VIRAL AND BACTERIAL ETIOLOGY IN HUMANS AND ANIMALS AND COMPOSITION FOR ITS IMPLEMENTATION
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
IE870577L (en) Topical amide preparation
NO952212L (en) Preparations containing acyclovir-like compounds and 2'-vinyl-substituted nucleoside analogues for the treatment of viral infections
KR890007737A (en) Anti-caking agents
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
GR1001006B (en) Method for preparating and using antimicrobiac or antibacterial compositions
JO1231B1 (en) Method of treating protozoal diseases
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
MY109685A (en) Method for treating hepatitis b carriers with minimal disease
NO920257D0 (en) THERAPEUTIC ACTIVE RELATIONSHIPS, PROCEDURE FOR THEIR PREPARATION AND APPLICATION OF THEM